Types of Pulmonary hypetension
"pulmonary hypertension" classification
| Sub-type | Notes |
|---|---|
| 1.1 Idiopathic PAH (IPAH) | Most common; mean age at diagnosis now 54-68 years; female predominance (~3:1) |
| 1.2 Heritable PAH | Most commonly BMPR2 mutation; younger at diagnosis, more severe |
| 1.3 Drug- and toxin-induced | Anorexigens (fenfluramine), methamphetamine, dasatinib |
| 1.4 Associated PAH | Connective tissue disease, HIV, portal hypertension (portopulmonary), congenital heart disease, schistosomiasis |
| 1.5 PAH long-term responders to CCBs | Acute vasoreactivity test positive subset |
| 1.6 PAH with PVOD/PCH features | Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis overlap |
| 1.7 Persistent PH of the newborn |
Epidemiology: PAH is rare (~15 cases per million adults) but disproportionately affects young, otherwise healthy women. In resource-rich countries, PAH accounts for only ~3% of pulmonary vascular disease.
| Sub-type |
|---|
| 2.1 HF with preserved ejection fraction (HFpEF) - increasingly the leading cause |
| 2.2 HF with reduced/mildly reduced ejection fraction (HFrEF) |
| 2.3 Valvular heart disease |
| 2.4 Congenital/acquired cardiovascular conditions causing postcapillary PH |
| Sub-type |
|---|
| 3.1 Obstructive lung disease (COPD) - ~1/3 of end-stage COPD patients referred for transplant have PH |
| 3.2 Restrictive lung disease (ILD, pulmonary fibrosis) |
| 3.3 Mixed obstructive/restrictive pattern |
| 3.4 Hypoventilation syndromes (OSA, obesity-hypoventilation/Pickwickian) - usually mild PH |
| 3.5 Hypoxia without lung disease (e.g. high altitude) |
| 3.6 Developmental lung disorders |
| Sub-type |
|---|
| 4.1 Chronic thromboembolic PH (CTEPH) |
| 4.2 Other pulmonary artery obstructions (sarcomas, other malignant/non-malignant tumors, hydatid cysts) |
CTEPH can be clinically identical to IPAH - distinguishing them is essential because treatment differs fundamentally.
| Sub-type | Examples |
|---|---|
| 5.1 Hematological disorders | Chronic hemolytic anemia, myeloproliferative disorders |
| 5.2 Systemic disorders | Sarcoidosis, pulmonary Langerhans cell histiocytosis, neurofibromatosis type 1 |
| 5.3 Metabolic disorders | Glycogen storage disease, Gaucher disease, thyroid disorders |
| 5.4 Chronic renal failure (with or without hemodialysis) | |
| 5.5 Pulmonary tumor thrombotic microangiopathy | |
| 5.6 Fibrosing mediastinitis |

| Hemodynamic Type | mPAP | PAWP | PVR | Associated Groups |
|---|---|---|---|---|
| Precapillary PH | >20 mmHg | ≤15 mmHg | >2 WU | Groups 1, 3, 4, 5 |
| Postcapillary PH | >20 mmHg | >15 mmHg | - | Group 2 |
| Combined pre+postcapillary | >20 mmHg | >15 mmHg | >2 WU | Group 2 (severe) |
1 day itinerary for travel near Ahmedabad
What kind of experience are you looking for? · How far are you willing to travel from Ahmedabad?
nature outdoor day trip within 50 km Ahmedabad 2025
Thol Lake Bird Sanctuary Indroda Nature Park Ahmedabad visit timings entry fee 2025
Today is Sunday - perfect timing. It's also monsoon season (July), so the landscape is lush green, lakes are full, and birds are active.
| Time | Place | Distance from AMD | Entry |
|---|---|---|---|
| 6:00 - 9:30 AM | Thol Lake Bird Sanctuary | 25 km | ₹50 |
| 10:30 AM - 1:30 PM | Indroda Nature Park, Gandhinagar | 25 km | ~₹50 |
| 1:30 - 2:30 PM | Lunch in Gandhinagar | - | - |
| 3:00 - 3:30 PM | Adalaj Stepwell (optional) | 18 km | Free |
| 5:30 PM | Back in Ahmedabad | - | - |
How much is the total population if ahmedabad
Ahmedabad total population 2024 2025
| Scope | Population | Source |
|---|---|---|
| City proper (municipal limits) | ~7.7 million | Wikipedia / 2023 estimate |
| Urban agglomeration | ~8.77 million | Wikipedia / 2023 estimate |
| Metro area projection (2026) | ~10.59 million | World Population Review |
| Last official census (2011) | 5.57 million (city) | Census of India |